CommonHealth Global Services to be Led by Former EURO RSCG Top Executive.

PARSIPPANY, N.J.--(BUSINESS WIRE)--Aug. 5, 1999--

Appointment of Daniel Teper Part of Company Mission to

"Help Clients Grow Brands" Worldwide

CommonHealth today announced the appointment of Daniel Teper, PharmD, MBA, to the position of executive vice president, group company director, global services.

Formerly president of EURO RSCG WORLDWIDE's European healthcare group, Dr. Teper, 39, will be responsible for leading and developing CommonHealth's global client relationships, which already include AstraZeneca, Johnson & Johnson, Pharmacia & Upjohn and Procter & Gamble.

CommonHealth, the world's largest healthcare-communications resource, with 1998 billings of more than $1 billion, is a member of the WPP Group (LSE: WPPL.L;NASDAQ/ADR:WPPGY) of companies.

Dr. Teper, who will report to CommonHealth group company CEO Gil Bashe, will work with the presidents of CommonHealth's 15 divisions worldwide to further build the network's global offering and corpus of best-practice knowledge.

Before his three-year tenure with EURO RSCG on the agency side, Dr. Teper held strategic positions with several of the world's leading pharmaceutical companies, both in Europe and the United States.

"Clients today are looking for strategic partners who can help them answer the question: `What's the best way to create a health brand with a single, compelling message of value in the U.S. and Europe, where 85 percent of the market currently resides?'," said Gil Bashe.

"CommonHealth's vision for helping clients build brands and Daniel's ability to execute against that vision, transnationally, will be a powerful combination," Mr. Bashe predicted.

Dr. Teper's resume includes Paris-based Synthelabo, where he served as chief operating officer of Laboratories Delagrange; Glaxo France, where he held the title of vice president, marketing and sales; Sandoz Pharmaceuticals Corporation in East Hanover, New Jersey, where he served as marketing director, cardiovascular; as well as a position with Sandoz Ltd., in Basel, where he began his global-marketing career.

During his five-year tenure with Sandoz in the U.S., Dr. Teper was the recipient of the company's coveted Marketing Excellence Award.

Dr. Teper holds a Master of Business Administration degree from INSEAD, Fontainebleau (France), where he was the J. Salmon Scholar; and a Doctor of Pharmacy degree, summa cum laude, from the Paris XI University School of Pharmacy in Chatenay-Malabry.

A successful entrepreneur, he started and subsequently sold the Paris-based pharmaceutical company Wintec Pharma. "Perspective means a great deal in a business as fast-changing as healthcare communications, and Daniel has perspective to spare," said CommonHealth's Bashe. "It was one of the qualities that drew us to him, and we intend to use it shamelessly to the benefit of our clients."

For his part, Dr. Teper cited CommonHealth's "unique collaborative philosophy" as a factor in his decision to join CommonHealth. "Many networks are focused more on their own structures than on anticipating and delivering on client needs. At CommonHealth, client need trumps structure," he noted.

CommonHealth comprises Adient, CommonHealth Australia, CommonHealth Europe, CommonHealth Kyowa, Enterprise IG Health, Gowers Advertising, Health Learning Systems, the Hill & Knowlton Health and Pharmaceutical Practice, the OZM Group and a partnership in China with the Ogilvy Healthcare Network, ProCom International, The Conectics Group, The Quantum Group, The Xchange Group and Thomas Ferguson Associates.

For five consecutive years, CommonHealth was named by its peers the nation's "most admired" healthcare-communications resource, as reported in Med Ad News.